Research Topics
| A H ClaytonSummaryAffiliation: University of Virginia Country: USA Publications
| Collaborators
|
Detail Information
Publications
Prevalence of sexual dysfunction among newer antidepressantsAnita H Clayton
Department of Psychiatric Medicine, University of Virginia, Charlottesville 22903, USA
J Clin Psychiatry 63:357-66. 2002....
Etiology of female sexual dysfunctionAnita H Clayton
Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA 22903, USA
Womens Health (Lond Engl) 9:135-7. 2013..They also show that specific types of sexual problems may be related more to nonshared environmental factors. Overall, the results suggest FSD is multifactorial...
An evaluation of sexual functioning in employed outpatients with major depressive disorder treated with desvenlafaxine 50 mg or placeboAnita H Clayton
University of Virginia, Charlottesville, VA 22908 062, USA
J Sex Med 10:768-76. 2013..The symptoms of major depressive disorder (MDD) include sexual dysfunction, but antidepressant pharmacotherapies are also associated with treatment-emergent sexual dysfunction...
Validity of the decreased sexual desire screener for diagnosing hypoactive sexual desire disorderAnita H Clayton
Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, Virginia 22903, USA
J Sex Marital Ther 39:132-43. 2013..The sensitivity of the decreased sexual desire screener was 0.946 in a North American trial and 0.960 in a European trial...
Validation of the decreased sexual desire screener (DSDS): a brief diagnostic instrument for generalized acquired female hypoactive sexual desire disorder (HSDD)Anita H Clayton
Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA 22903, USA
J Sex Med 6:730-8. 2009....
Recognition of depression among women presenting with menopausal symptomsAnita Clayton
University of Virginia Healthsystem, Charlottlesville, VA 22908, USA
Menopause 15:758-67. 2008..Depression is particularly prevalent among women in the reproductive years. This article reviews research on the risk of depression during the transition to menopause and discusses screening methods and management options...
The impact of physical illness on sexual dysfunctionAnita Clayton
Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA 22908, USA
Adv Psychosom Med 29:70-88. 2008..Thus, a separate section on medications that impair sexual functioning is presented. A table of common medications as a quick reference to their effects on each stage of the sexual cycle is also provided...
Symptoms related to the menstrual cycle: diagnosis, prevalence, and treatmentAnita H Clayton
Department of Psychiatry and Neurobehavioral Sciences, University of Virginia Health System, Charlottesville, VA 22908, USA
J Psychiatr Pract 14:13-21. 2008..g., with oral contraceptives). Treatment with oral contraceptives (OCs), particularly extended or continuous use, may significantly reduce the incidence of menstrual cycle-related symptoms...
Epidemiology and neurobiology of female sexual dysfunctionAnita H Clayton
Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA 22903, USA
J Sex Med 4:260-8. 2007..Sexual dysfunction is a disturbance in sexual functioning involving one or multiple phases of the sexual response cycle or pain associated with sexual activity, while a sexual disorder includes both dysfunction and marked distress...
Extended-release bupropion: an antidepressant with a broad spectrum of therapeutic activity?Anita H Clayton
Department of Psychiatry and Neurobehavioural Sciences, University of Virginia, 2955 Ivy Road, Northridge Suite 210, Charlottesville, VA 22903, USA
Expert Opin Pharmacother 8:457-66. 2007..Thus, bupropion has proven effective across a broad spectrum of depressive conditions, subtypes and comorbidities...
Major depressive disorder, antidepressants, and sexual dysfunctionAnita H Clayton
Department of Psychiatric Medicine, University of Virginia Health System, Charlottesville, 22908, USA
J Clin Psychiatry 67:33-7. 2006..The addition of antidotal therapy has been proven to be among the effective management strategies for sexual dysfunction. However, due to a lack of systematic data, additional studies are warranted to further investigate these findings...
An integrated analysis of the safety and tolerability of desvenlafaxine compared with placebo in the treatment of major depressive disorderAnita H Clayton
Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA 22903, USA
CNS Spectr 14:183-95. 2009..The purpose of this investigation was to characterize the safety and tolerability of desvenlafaxine (administered as desvenlafaxine succinate) in treating depression...
The impact of mental illness and psychotropic medications on sexual functioning: the evidence and managementAnita H Clayton
University of Virginia, Department of Psychiatry and Neurobehavioral Sciences, Charlottesville, VA 22903, USA
J Sex Med 6:1200-11; quiz 1212-3. 2009..Sexual dysfunction (SD) occurs frequently in patients with psychiatric illness...
Potential role of androgens in the treatment of hypoactive sexual desire in womenAnita H Clayton
University of Virginia, 2955 Ivy Road, Northridge Suite 210, Charlottesville, VA, USA
Womens Health (Lond Engl) 1:191-3. 2005..This study suggests that supplemental testosterone may improve sexual desire in women with hypoactive sexual desire without hypoandrogenism...
Female sexual dysfunctionAnita H Clayton
Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Northridge Suite 210, Charlottesville, VA 22903, USA
Obstet Gynecol Clin North Am 36:861-76, xi. 2009..A variety of treatment modalities exist, though current research has not yet provided Food and Drug Administration approved therapies for sexual disorders in women...
Standards for clinical trials in sexual dysfunction in women: research designs and outcomes assessmentAnita H Clayton
University of Virginia Health System, Department of Psychiatry, and Neurobehavioral Sciences, Charlottesville, VA 22903, USA
J Sex Med 7:541-60. 2010..Clinical trial design in female sexual dysfunction (FSD) is an evolving science, with some areas of controversy...
Female sexual dysfunctionAnita H Clayton
Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, PO Box 801210, Charlottesville, VA 22908 1210, USA
Psychiatr Clin North Am 33:323-38. 2010..A variety of treatment modalities exist, though current research has not yet provided Food and Drug Administration-approved therapies for sexual disorders in women...
The pathophysiology of hypoactive sexual desire disorder in womenAnita H Clayton
Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA 22903, USA
Int J Gynaecol Obstet 110:7-11. 2010..A greater understanding of the complex pathophysiology of HSDD would improve the identification and management of women for whom low sexual desire is a concern...
Validation of the sexual interest and desire inventory-female in hypoactive sexual desire disorderAnita H Clayton
Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA, USA
J Sex Med 7:3918-28. 2010..The Sexual Interest and Desire Inventory-Female (SIDI-F) is a 13-item scale developed as a clinician-administered assessment tool to measure hypoactive sexual desire disorder (HSDD) severity in women...
Flibanserin: a potential treatment for Hypoactive Sexual Desire Disorder in premenopausal womenA H Clayton
Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA 22903, USA
Womens Health (Lond Engl) 6:639-53. 2010..The aim of this article is to present an overview of the pharmacology, clinical efficacy and safety of flibanserin. Flibanserin is an investigational drug that is not licensed for any indication in any country...
Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studiesAnita H Clayton
Department of Psychiatric Medicine, University of Virginia Health System, Charlottesville, USA
J Clin Psychiatry 67:736-46. 2006..To compare the effects on sexual functioning and the antidepressant efficacy of once-daily bupropion extended release (XL) and escitalopram in adults with major depressive disorder (MDD)...
Assessment of sexual functioning during the menstrual cycleA H Clayton
University of Virginia, Charlottesville, USA
J Sex Marital Ther 25:281-91. 1999..The 24 women who returned for the second and third visits reported less frequent orgasms and less satisfaction from their orgasms premenstrually than during midcycle...
Sex differences in clinical presentation and response in panic disorder: pooled data from sertraline treatment studiesA H Clayton
University of Virginia School of Medicine, Charlottesville, VA 22903, USA
Arch Womens Ment Health 9:151-7. 2006..Gender differences in clinical presentation and response to sertraline treatment were examined for patients diagnosed with DSM-III-R panic disorder with or without agoraphobia...
Exploratory study of premenstrual symptoms and serotonin variabilityA H Clayton
Department of Psychiatric Medicine, University of Virginia, Charlottesville, Virginia 22903, USA
Arch Womens Ment Health 9:51-7. 2006..The three groups exhibited potentially significant differences in several biological markers. This study's results are consistent with a hypothesis implicating serotonin in the generation of premenstrual symptomology...
A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunctionAnita H Clayton
University of Virginia, Charlottesville, VA 22903, USA
J Clin Psychiatry 65:62-7. 2004..Exploratory analyses of the association of testosterone and sexual functioning in women in the study were also performed...
Sexual function and dysfunction in womenAnita H Clayton
Department of Psychiatry, University of Virginia Health System, Northridge Building, Suite 210, 2955 Ivy Road, Charlottesville, VA 22903, USA
Psychiatr Clin North Am 26:673-82. 2003..Interventions may also be multifaceted, ranging from sex education to psychotherapy to medical treatment. Restoration of sexual functioning is the goal of treatment, but more research is needed for true success to be realized...
Reliability and validity of the Sexual Interest and Desire Inventory-Female (SIDI-F), a scale designed to measure severity of female hypoactive sexual desire disorderAnita H Clayton
Department of Psychiatric Medicine, University of Virgina Health System, Charlottesville, Virginia 22903, USA
J Sex Marital Ther 32:115-35. 2006..Taken together, the results of the present investigation indicate that the SIDI-F is a reliable and valid measure of HSDD severity, independent of relationship issues...
Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorderAnita H Clayton
University of Virginia, Department of Psychiatric Medicine, Charlottesville 22903, USA
Int Clin Psychopharmacol 18:151-6. 2003..These results suggest that reboxetine may be of particular benefit for patients at risk for sexual dysfunction with SSRIs...
Combination therapy in the treatment of major depressive disorder complicated by fibromyalgia and menopauseAnita H Clayton
Department of Psychiatric Medicine, University of Virginia, Charlottesville, VA 22903, USA
Psychosomatics 43:491-3. 2002
Female sexual dysfunction related to depression and antidepressant medicationsAnita H Clayton
University of Virginia Health System, 2955 Ivy Road, Northridge Suite 210, Charlottesville, VA 22908, USA
Curr Womens Health Rep 2:182-7. 2002..Emerging data on the pathophysiology of sexual function and dysfunction, and new treatment options may lead to improved quality of life for women diagnosed with depression...
Burden of phase-specific sexual dysfunction with SSRIsAnita Clayton
Department of Psychiatric Medicine, University of Virginia, Charlottesville, VA, USA
J Affect Disord 91:27-32. 2006..This study examines phase-specific sexual dysfunction among patients who are being treated for major depression and who do not meet criteria for global sexual dysfunction...
Combination therapy in fibromyalgiaA H Clayton
Department of Psychiatric Medicine, University of Virginia, Charlottesville, VA 22908 0623, USA
Curr Pharm Des 12:11-6. 2006..Treatment should therefore be tailored accordingly. Thus, it is often necessary to combine different options in order to achieve the maximum benefit in patients suffering from fibromyalgia...
Substitution of an SSRI with bupropion sustained release following SSRI-induced sexual dysfunctionA H Clayton
Department of Psychiatric Medicine, University of Virginia, Charlottesville 22903, USA
J Clin Psychiatry 62:185-90. 2001..Results show that sexual functioning improves after the addition of bupropion SR to SSRI treatment and continues to improve, after discontinuation of the SSRI, with bupropion SR treatment alone...
Recognition and assessment of sexual dysfunction associated with depressionA H Clayton
Department of Psychiatric Medicine, University of Virginia School of Medicine, Charlottesville 22908, USA
J Clin Psychiatry 62:5-9. 2001..Appropriate evaluation of sexual functioning associated with depression could help reduce the enormous societal costs of this disorder...
A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerabilityMichael E Thase
Department of Psychiatry, University of Pittsburgh Medical Center, Western Psychiatric Institute, Pittsburgh, PA, USA
J Clin Psychopharmacol 26:482-8. 2006..In conclusion, in this patient population (ie, relatively young, sexually active outpatients), bupropion XL was at least as effective as venlafaxine XR and had a significantly more favorable sexual side effect profile...
Factors predicting reduced antidepressant response: experience with the SNRI duloxetine in patients with major depressionRobert H Howland
Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
Ann Clin Psychiatry 20:209-18. 2008..To identify putative demographic and clinical variables that correlate with antidepressant response to the SNRI duloxetine in major depression...
Reliability and construct validity of the Changes in Sexual Functioning Questionnaire short-form (CSFQ-14)Adrienne Keller
Department of Psychiatric Medicine, University of Virginia, Charlottesville, 22908, USA
J Sex Marital Ther 32:43-52. 2006..Factor analysis confirms the construct validity of the CSFQ-14 as a global measure of sexual dysfunction. The CSFQ-14 and the individual scales exhibit strong internal reliability...
Relative antidepressant efficacy of bupropion and the selective serotonin reuptake inhibitors in major depressive disorder: gender-age interactionsGeorge I Papakostas
Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA
Int Clin Psychopharmacol 22:226-9. 2007..This finding could, however, not be replicated when improvement in anxious/somatic symptoms was defined as a continuous measure...
Sertraline in the treatment of panic disorderCassandra D Hobgood
University of Virginia Health System, Department of Psychiatry and Neurobehavioral Sciences, Charlottesville, Virginia 22903, USA
Drugs Today (Barc) 45:351-61. 2009..When reviewed in context with the efficacy trials, a compelling argument can be made for making sertraline a first choice among the serotonin reuptake inhibitors in the treatment of PD...
Sexual functioning of Latino women seeking outpatient gynecologic careKathie L Hullfish
Department of Obstetrics and Gynecology, University of Virginia Health System, Charlottesville, VA 22908, USA
J Sex Med 6:61-9. 2009..A sample of Latino women from an ambulatory obstetrics and gynecology (Ob/Gyn) clinic were queried about their sexual functioning using the Changes in Sexual Functioning Questionnaire (CSFQ-14)...
Symptoms of sexual dysfunction in patients treated for major depressive disorder: a meta-analysis comparing selegiline transdermal system and placebo using a patient-rated scaleAnita H Clayton
Department of Psychiatry and Neurobehavioral Sciences, University of Virginia Health System, Charlottesville, VA 22908, USA
J Clin Psychiatry 68:1860-6. 2007..The objective of this study was to examine the impact of STS 6 mg/24 hours on various domains of sexual function in patients with major depressive disorder (MDD), using a patient-rated questionnaire...
Gender differences in clinical psychopharmacologyAnita H Clayton
University of Virginia, Charlottesville, VA, USA
J Clin Psychiatry 66:1191. 2005
Chronic episodic disorders in womenJulia K Warnock
Department of Psychiatry, University of Oklahoma Health Sciences Center Tulsa, 4502 East 41st Street, Tulsa, OK 74135 2553, USA
Psychiatr Clin North Am 26:725-40. 2003..Thus, an increased understanding of the CED may result in improved treatment and functioning of many patients...
Serotonergic activation rescues reproductive function in fasted mice: does serotonin mediate the metabolic effects of leptin on reproduction?Shannon D Sullivan
Department of Medicine, University of Virginia, Charlottesville, Virginia 22908, USA
Biol Reprod 66:1702-6. 2002..Together, these data demonstrate a permissive role for serotonergic systems in the metabolic control of reproduction and are consistent with the hypothesis that serotonergic neurons convey leptin signals to GnRH neurons...
Female sexual dysfunctions: what controversy?Anita H Clayton
University of Virginia, Charlottesville, USA
J Clin Psychiatry 67:991-2. 2006
Serotonin 2A -1438 G/A and G-protein Beta3 subunit C825T polymorphisms in patients with depression and SSRI-associated sexual side-effectsJeffrey R Bishop
University of Illinois at Chicago College of Pharmacy, Chicago, IL, USA
Neuropsychopharmacology 31:2281-8. 2006..6; p=0.046). Furthermore, the 5HT2A -1438 GG genotype was a significant predictor of lower arousal scores (p=0.022) after accounting for other measures. There was no significant relationship between any outcome measure and GNB3 genotype...
Consensus statement and research needs: the role of dopamine and norepinephrine in depression and antidepressant treatmentDavid J Nutt
Psychopharmacology Unit, School of Medical Sciences, University of Bristol, Bristol, UK
J Clin Psychiatry 67:46-9. 2006..In addition, the faculty discussed the importance of patient psychoeducation and self-management as well as the ways in which disease models of depression affect treatment...
Treating depression complicated by comorbid medical illness or anxietyMadhukar H Trivedi
Department of Psychiatry and Mood Disorders Research Program and Clinic, University of Texas Southwestern Medical Center, Dallas, USA
J Clin Psychiatry 68:e01. 2007....
Assessing the onset of antidepressant-induced sexual dysfunction using interactive voice response technologyJudith A Dunn
Pfizer Global Research and Development, New London, Conn, USA
J Clin Psychiatry 68:525-32. 2007..The current study was designed to evaluate the validity of obtaining CSFQ data using interactive voice response (IVR) technology...
Physician attitudes regarding hypoactive sexual desire disorder in a primary care clinic: a pilot studyVeronica Harsh
National Institutes of Mental Health, Behavioral Endocrinology, Bethesda, MD, USA
J Sex Med 5:640-5. 2008..Female sexual dysfunction (FSD), in particular, complaints of low desire, affects many American women. Despite the impact FSD may have on these women, many do not present their symptoms to their physicians...
Sexual medicine education: review and commentarySharon J Parish
Albert Einstein College of Medicine, Bronx, NY, USA
J Sex Med 4:259-67; quiz 268. 2007..Sexual medicine education is an important and fundamental topic not adequately represented in most undergraduate and residency training programs...
Biochemical evidence of the placebo effect during the treatment of menstrual migrainesAnita H Clayton
J Clin Psychopharmacol 25:400-1. 2005
